Biotech startup begins plotting Dayton move

Story excerpt provided by Dayton Business Journal.

Written by Tristan Navera.

A bio-tech startup is quickly gathering the venture capital it needs to begin the next stages of its growth, which will mean an investment in Dayton.

Iscemia Care, founded in Cincinnati, is finishing out its latest round of clinical validation — putting it one clinical trial away from entering the market. Now the startup is preparing for its next steps to respond to that, which will bring it to Dayton. It markets a blood test for timely diagnosis and treatment of strokes.

Click here to read the complete article.

Originally published July 29, 2016.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: